Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>

François Mach, Colin Baigent, Alberico L. Catapano et al. · European Heart Journal · 2019 · 8.9K citations · Full text

Medicine, Cardiology, Internal Medicine +17

Major Lipids, Apolipoproteins, and Risk of Vascular Disease

JAMA · 2009 · 2.8K citations · Full text

Medicine, Cardiology, Epidemiologic Methods +16

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Éric Bruckert, Robert A. Hegele, Jan Albert Kuivenhoven et al. · European Heart Journal · 2014 · 1.1K citations · Full text

Medicine, Cardiology, Genetics +17

Evinacumab for Homozygous Familial Hypercholesterolemia

Frederick J. Raal, Robert S. Rosenson, Laurens F. Reeskamp et al. · New England Journal of Medicine · 2020 · 764 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Marina Cuchel, Emma A. Meagher, Hendrik du Toit Theron et al. · The Lancet · 2012 · 740 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +12